18F-AV-1451 PET Imaging in Professional Fighters

Trial Profile

18F-AV-1451 PET Imaging in Professional Fighters

Completed
Phase of Trial: Phase I

Latest Information Update: 18 Apr 2017

At a glance

  • Drugs Flortaucipir-F-18 (Primary)
  • Indications Alzheimer's disease; Cognition disorders
  • Focus Diagnostic use
  • Sponsors Avid Radiopharmaceuticals
  • Most Recent Events

    • 13 Apr 2017 Status changed from recruiting to completed.
    • 27 May 2016 Planned End Date changed from 1 Nov 2015 to 1 Jan 2017.
    • 27 May 2016 Planned primary completion date changed from 1 Nov 2015 to 1 Jan 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top